BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 17785232)

  • 1. Reply to G-C Chen et al.
    Del Gobbo LC; Falk MC; Feldman R; Lewis K; Mozaffarian D
    Am J Clin Nutr; 2016 Apr; 103(4):1186-7. PubMed ID: 27037364
    [No Abstract]   [Full Text] [Related]  

  • 2. Nut consumption, lipid profile, and health outcomes.
    Chen GC; Wan ZX; Qin LQ
    Am J Clin Nutr; 2016 Apr; 103(4):1185-6. PubMed ID: 27037363
    [No Abstract]   [Full Text] [Related]  

  • 3. [Not Available].
    Schumacher B
    MMW Fortschr Med; 2023 Oct; 165(18):16-17. PubMed ID: 37828309
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I've heard that a measurement called apo B may be better a predicting heart attacks than LDL cholesterol levels. Should I be tested for apo B?
    Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):8. PubMed ID: 15602781
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: population-based cohort study.
    Onat A; Can G; Ciçek G; Ayhan E; Doğan Y
    Clin Biochem; 2010 Dec; 43(18):1381-6. PubMed ID: 20816677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Total variation of LDL-cholesterol and apolipoprotein B/ Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Coşkun A
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):331-2; author reply 332. PubMed ID: 17785232
    [No Abstract]   [Full Text] [Related]  

  • 9. [Apolipoprotein B and LDL cholesterol: which parameter(s) should be included in the assessment of cardiovascular risk?].
    Bloch S; Couderc R
    Ann Biol Clin (Paris); 1998; 56(5):539-44. PubMed ID: 9769484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The apoB/apoA-I ratio is better myocardial infarction marker than lipids].
    Walldius G; Angelin B; Eriksson M
    Lakartidningen; 2006 Mar 8-14; 103(10):751-2. PubMed ID: 16610201
    [No Abstract]   [Full Text] [Related]  

  • 11. Advanced lipoprotein testing: recommendations based on current evidence.
    Lau JF; Smith DA
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):1-31. PubMed ID: 19217510
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.